Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/35029197http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/35029197http://www.w3.org/2000/01/rdf-schema#comment"

Objectives

Investigate polymorphisms and expressions of human leukocyte antigen-G (HLA-G), galectin-1 (Gal-1), and interleukin-10 (IL-10) in people living with HIV (PLHIV) with and without comorbidities to help understanding the mechanisms involved in triggering these disorders in PLHIV and in their prognosis.

Design

Here we evaluated the potential correlation between the genetic polymorphism and/or protein levels of HLA-G, Gal-1, and IL-10 with and without comorbidities of PLHIV.

Methods

Two hundred HIV patients under antiretroviral treatment (83 with comorbidities and 117 without comorbidities) and 200 healthy individuals (controls) were genotyped, using PCR, for HLA-G 14-base pair polymorphism located at the 3' untranslated region in exon 8 insertion/insertion (Ins/Ins: low HLA-G expression) or deletion/deletion (Del/Del: high HLA-G expression). Soluble levels of HLA-G (sHLA-G), Gal-1, and IL-10 were quantified by enzyme-linked immunosorbet assay.

Results

HIV patients without comorbidities exhibited higher frequency of 14-base pair Del/Del genotype than HIV patients with comorbidities. As expected, HIV patients Ins/Ins with and without comorbidities produced less sHLA-G than controls. However, HIV patients Del/Del with comorbidities expressed sHLA-G more than controls and HIV patients Del/Del without comorbidities. Interestingly, patients that showed low levels sHLA-G, and presence of comorbidities, exhibited high Gal-1 serum levels. However, an increase in soluble levels of IL-10 in PLHIV was observed when compared to controls, especially in the PLHIV group without comorbidities suggesting, a protective role of IL-10 in the development of comorbidities.

Conclusions

These data suggested that the high expression of sHLA-G and IL-10 or Gal-1 could be associated and could be associated with the development or not of comorbidities in PLHIV."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.org/dc/terms/identifier"doi:10.1097/md.0000000000028489"xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Dias-Baruffi M."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Arthur C."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Stowell S.R."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Ayres L.R."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Cataldi-Rodrigues L."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Cortelette N.A."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Guimaraes D.A.M."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Souza N.O."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/author"Tres Pancoto J.A."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/date"2022"xsd:gYear
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/name"Medicine (Baltimore)"xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/pages"e28489"xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/title"Functional evaluation of immunoregulatory molecules HLA-G, galectin-1, and IL-10 in people living with HIV."xsd:string
http://purl.uniprot.org/citations/35029197http://purl.uniprot.org/core/volume"101"xsd:string
http://purl.uniprot.org/citations/35029197http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/35029197
http://purl.uniprot.org/citations/35029197http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/35029197
http://purl.uniprot.org/uniprot/#_A0A0H4M9X9-mappedCitation-35029197http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35029197
http://purl.uniprot.org/uniprot/#_A0A0H4M9Y0-mappedCitation-35029197http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35029197
http://purl.uniprot.org/uniprot/#_A0A0H4M9Y1-mappedCitation-35029197http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35029197
http://purl.uniprot.org/uniprot/#_A0A0H4M9Y2-mappedCitation-35029197http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35029197
http://purl.uniprot.org/uniprot/#_A0A0H4M9Y3-mappedCitation-35029197http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35029197
http://purl.uniprot.org/uniprot/#_A0A0H4M9Y6-mappedCitation-35029197http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/35029197
▶